123 Main Street, New York, NY 10001

Top Navigation with Mega Menu

Co-Dx™ shows rising price performance

Company’s stock jumps more than 2000%.

With demand for its tests and other molecular tools taking off in January 2020, CoDx’s stock soars more than 2000% in just over a week. And a new 91 Relative Strength Rating shows Co-Dx outperforming over 90% of all stocks. Investor’s Business Daily explores other key ratings and cites growing earnings and revenue increases as reasons to watch Co-Dx in the future.

Watch the video here: